Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Nicholas J. Vogelzang, MD, considers genomics and systemic therapy in advanced prostate cancer

Dr. Vogelzang, MD, Vice Chair, SWOG GU Committee Research, Medical Director, US Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, elaborates on how genomics are being incorporated into the management of systemic therapy in advanced prostate cancer.

Tags: ASCO GU Conference CoverageProstate

Published: 10 February 2018

Recent Videos

video

Shirish M. Gadgeel MBBS, comments on significant studies in ALK+ NSCLC from ESMO 2019

Shirish M. Gadgeel MBBS, Mary Lou Kennedy Research Professor in Thoracic Oncology, Co-leader, Thoracic Oncology Research Program, University of Michigan, ...

video

Véronique Diéras, MD, on the optimal setting in which to receive a PARP inhibitor

Dr. Diéras, Senior Medical Oncologist, Head, Breast Cancer Group, Department of Medical Oncology, Centre Eugène Marquis, Rennes, France, tells us ...

video

Robert L. Coleman, MD, FACOG, FACS, on takeaways from the ovarian plenary session at ESMO '19

Dr. Coleman, Professor, Department of Gynecologic Oncology and Reproductive Medicine, Ann Rife Cox Chair in Gynecology, MD Anderson Cancer Center, ...

video

Amer Zeidan, MBBS, comments on the influx of investigational oral agents in myeloid malignancies

Amer Zeidan, MBBS, Associate Professor of Hematology, Yale School of Medicine, Yale Cancer Center, comments on the influx of investigational ...

video

Arndt Vogel, MD, elaborates on some of the key takeaways from the GO30140 trial

Dr. Vogel, Professor of Gastrointestinal Oncology in the Department of Gastroenterology, Hepatology and Endocrinology, Managing Senior Consultant, Hannover Medical School, ...

video

George Sledge, MD, explains how MONARCH-2 may impact the current standard of care

Dr. Sledge, Professor and Chief, Division of Oncology, Stanford Cancer Center, Stanford University School of Medicine, explains how the results ...

video

Dennis J. Slamon, MD, PhD, discusses implications from the MONALEESA-3 trial

Dr. Slamon, Professor and Chief of Hematology/Oncology, UCLA Department of Medicine, Director of Clinical/Translational Research, Director of the Revlon/UCLA Women's ...

video

Nader Sanai, MD, offers perspective on the challenges in treating glioblastoma

Dr. Sanai, Department of Neurosurgery, Director, Ivy Brain Tumor Center, offers perspective on some of the challenges in treating and ...

video

Christian Rolfo, MD, PhD, MBA, on the role of liquid biopsy in the treatment of lung cancer

Dr. Rolfo, Professor, Oncology, Director, Thoracic Medical Oncology and Early Clinical Trials, University of Maryland, Marlene and Stewart Greenebaum Comprehensive ...

video

Ulrik Lassen, MD, PhD, on whether testing for TRK fusion is easy and reliable

Dr. Lassen, Professor, Medical Oncology; Head, Department of Oncology, Rigshospitalet, Copenhagen, Denmark, elaborates on whether it is easy and reliable ...

Related Videos

video-image

Stefan Kasper, MD, provides updates on the BEACON trial in BRAF-mutant CRC

video-image

Shirish M. Gadgeel MBBS, comments on significant studies in ALK+ NSCLC from ESMO 2019

video-image

Scott Kopetz, MD, explains how BRAF mutations figure into treatment algorithms for CRC

video-image

Ulrik Lassen, MD, PhD, on whether testing for TRK fusion is easy and reliable

video-image

Christian Rolfo, MD, PhD, MBA, on the role of liquid biopsy in the treatment of lung cancer

video-image

Nader Sanai, MD, offers perspective on the challenges in treating glioblastoma

video-image

Brian Van Tine, MD, shares some of the top studies in sarcoma presented at ESMO 2019

video-image

Dennis J. Slamon, MD, PhD, discusses implications from the MONALEESA-3 trial

video-image

Arndt Vogel, MD, elaborates on the results of the CheckMate-459 study in HCC

video-image

George Sledge, MD, explains how MONARCH-2 may impact the current standard of care

video-image

Amer Zeidan, MBBS, on his study investigating onvansertib + cytarabine or decitabine in AML

video-image

Arndt Vogel, MD, elaborates on some of the key takeaways from the GO30140 trial

video-image

Robert L. Coleman, MD, FACOG, FACS, on the VELIA, PAOLA-1 and PRIMA studies

video-image

Amer Zeidan, MBBS, comments on the influx of investigational oral agents in myeloid malignancies

video-image

Véronique Diéras, MD, on BRCA-positive metastatic breast cancer & PARP inhibitors

video-image

Robert L. Coleman, MD, FACOG, FACS, on takeaways from the ovarian plenary session at ESMO '19

video-image

Shirish M. Gadgeel MBBS, speculates on the future of RET-altered NSCLC

video-image

Véronique Diéras, MD, on the optimal setting in which to receive a PARP inhibitor

video-image

Christian Rolfo, MD, PhD, MBA, on the development of RET-Fusion in NSCLC

video-image

Nader Sanai, MD, shares details from the most promising studies in glioma presented at ESMO 2019